$100M Buy Pressure & The MultiVM Leap: Injective's Master Plan
In crypto, we track developer activity and institutional inflows. Rarely do they peak simultaneously. @Injective ($INJ) has just aligned both vectors perfectly.
1. The Institutional Validation:
Pineapple Financial, a New York Stock Exchange listed company, has raised a $100 Million Digital Asset Treasury with the explicit intent to acquire INJ from the open market. This is a massive endorsement of Injective's architecture as the preferred layer for Wall Street. With a potential US ETF on the horizon, Injective is transitioning from a "DeFi Altcoin" to an "Institutional Asset Class."
2. The Technical Catalyst:
Simultaneously, the launch of the Native EVM (iSEVM) brings the "MultiVM" vision to life. This isn't just about compatibility; it’s about liquidity aggregation. Over 40+ dApps are ready to deploy, merging the developer depth of Ethereum with Injective’s sub-second finality.
3. The RWA Endgame:
From tokenized Nvidia stocks to Digital Asset Treasuries, Injective is delivering the RWA use cases that others only promise.
When you see a NYSE company buying the supply and a new EVM layer unlocking the dev activity, you aren't looking at speculation. You are looking at a repricing event.
